文传商讯

KATE, Japan’s No. 1 Makeup Brand, Launches Strategic Initiatives to Strengthen Business and Brand R
2025-06-05 23:12:32

European Commission Approves ADCETRIS (brentuximab vedotin) for the Treatment of Adult Patients with
2025-06-05 23:12:32